BRIEF published on 12/19/2025 at 12:05, 3 months 13 days ago Biotest AG annonce l'approbation par la FDA du Fesilty™ de Grifols Biotest AG Marché Américain Approbation De La FDA Grifols Thérapie Au Fibrinogène
BRIEF published on 12/19/2025 at 12:05, 3 months 13 days ago Biotest AG Announces FDA Approval of Grifols' Fesilty™ FDA Approval Biotest AG U.S. Market Grifols Fibrinogen Therapy
PRESS RELEASE published on 12/19/2025 at 12:00, 3 months 13 days ago Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) Biotest AG announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) for acute bleeding episodes in patients with fibrinogen deficiency Biotest AG Fibrinogen Grifols US FDA Approval Fesilty
BRIEF published on 11/13/2025 at 10:12, 4 months 18 days ago Biotest obtient l'autorisation de mise sur le marché de Prufibry® en Allemagne Biotest AG Essais Cliniques Marché Allemand Approbation Prufibry® Déficit En Fibrinogène
BRIEF published on 11/13/2025 at 10:12, 4 months 18 days ago Biotest Obtains Approval for Prufibry® in Germany Clinical Trials Biotest AG German Market Prufibry® Approval Fibrinogen Deficiency
PRESS RELEASE published on 11/13/2025 at 10:07, 4 months 18 days ago Biotest obtains approval for new human fibrinogen Prufibry® in Germany Biotest AG obtains approval in Germany for new human fibrinogen Prufibry®, expanding intensive care and coagulation factor portfolio with a life-saving therapy for congenital and acquired fibrinogen deficiency Germany Biotest AG Approval Human Fibrinogen Prufibry
BRIEF published on 11/07/2025 at 15:24, 4 months 24 days ago Biotest AG convoque une assemblée générale extraordinaire à la demande de Grifols Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
BRIEF published on 11/07/2025 at 15:24, 4 months 24 days ago Biotest AG Schedules Extraordinary General Meeting at Grifols' Request Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
PRESS RELEASE published on 11/07/2025 at 15:19, 4 months 24 days ago Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A. Biotest AG convenes an extraordinary general meeting at the request of Grifols S.A. to discuss changing its legal form to a partnership limited by shares (KGaA) on 17 December 2025 Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 10/23/2025 at 13:21, 5 months 9 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
Published on 04/02/2026 at 04:00, 1 hour 32 minutes ago MedMira Reports Second Quarter Results FY2025
Published on 04/02/2026 at 00:55, 4 hours 37 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 00:00, 5 hours 32 minutes ago Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Published on 04/01/2026 at 23:15, 6 hours 17 minutes ago Golden Minerals Reports Full Year 2025 Results
Published on 04/02/2026 at 00:52, 4 hours 39 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3H
Published on 04/01/2026 at 22:23, 7 hours 9 minutes ago EQS-Adhoc: Deutsche Börse AG: US court grants decision to plaintiffs’ group seeking turnover of assets attributed to Bank Markazi and held by Clearstream
Published on 04/01/2026 at 22:05, 7 hours 27 minutes ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers
Published on 04/01/2026 at 22:05, 7 hours 27 minutes ago Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Published on 04/01/2026 at 19:16, 10 hours 15 minutes ago Mars 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 04/01/2026 at 18:15, 11 hours 17 minutes ago Accor signs a memorandum of understanding on the sale of its stake in Essendi
Published on 04/01/2026 at 18:15, 11 hours 17 minutes ago Accor a signé un protocole d’accord pour la cession de sa participation dans Essendi
Published on 04/01/2026 at 18:02, 11 hours 30 minutes ago CP MOULINVEST : TRANSFERT DU CONTRAT DE LIQUIDITE AUPRES DE TPICAP
Published on 04/01/2026 at 18:00, 11 hours 32 minutes ago Closing of acquisition of Chaplin's World operating company
